<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD 2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">EXCLI J</journal-id><journal-id journal-id-type="iso-abbrev">EXCLI J</journal-id><journal-id journal-id-type="publisher-id">EXCLI J</journal-id><journal-title-group><journal-title>EXCLI Journal</journal-title></journal-title-group><issn pub-type="epub">1611-2156</issn><publisher><publisher-name>Leibniz Research Centre for Working Environment and Human Factors</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6868923</article-id><article-id pub-id-type="publisher-id">2019-1837</article-id><article-id pub-id-type="doi">10.17179/excli2019-1837</article-id><article-id pub-id-type="publisher-id">Doc1037</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Antiviral activity of flavonoids present in aerial parts of <italic>Marcetia taxifolia</italic> against Hepatitis B virus, Poliovirus, and Herpes Simplex Virus <italic>in vitro</italic></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ortega</surname><given-names>Joseph Thomas</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Serrano</surname><given-names>Mar&#x000ed;a Luisa</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Su&#x000e1;rez</surname><given-names>Al&#x000ed;rica Isabel</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Baptista</surname><given-names>Jani</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Pujol</surname><given-names>Flor Helene</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Cavallaro</surname><given-names>Luc&#x000ed;a Vicenta</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Campos</surname><given-names>H&#x000e9;ctor Rodolfo</given-names></name><xref ref-type="corresp" rid="COR1">*</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Rangel</surname><given-names>H&#x000e9;ctor Rafael</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib></contrib-group><aff id="A1">
<label>1</label>Laboratorio de Virolog&#x000ed;a Molecular, Centro de Microbiolog&#x000ed;a y Biolog&#x000ed;a Celular, Instituto Venezolano de Investigaciones Cient&#x000ed;ficas, Caracas, Venezuela</aff><aff id="A2">
<label>2</label>C&#x000e1;tedra de Virolog&#x000ed;a, Facultad de Farmacia y Bioqu&#x000ed;mica, Universidad de Buenos Aires, Argentina</aff><aff id="A3">
<label>3</label>Unidad de Qu&#x000ed;mica Medicinal, Facultad de Farmacia, Universidad Central de Venezuela, Caracas, Venezuela</aff><aff id="A4">
<label>4</label>Laboratorio de Productos Naturales, Facultad de Farmacia, Universidad Central de Venezuela, Caracas, Venezuela</aff><author-notes><corresp id="COR1">*To whom correspondence should be addressed: H&#x000e9;ctor Rodolfo Campos, C&#x000e1;tedra de Virolog&#x000ed;a, Facultad de Farmacia y Bioqu&#x000ed;mica, Universidad de Buenos Aires, E-mail: <email>rcampos@ffyb.uba.ar</email></corresp></author-notes><pub-date pub-type="epub"><day>05</day><month>11</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>18</volume><fpage>1037</fpage><lpage>1048</lpage><history><date date-type="received"><day>20</day><month>9</month><year>2019</year></date><date date-type="accepted"><day>29</day><month>10</month><year>2019</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2019 Ortega et al.</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>) You are free to copy, distribute and transmit the work, provided the original author and source are credited.</license-p></license></permissions><self-uri xlink:type="simple" xlink:href="https://www.excli.de/vol18/Campos_Rangel_05112019_proof.pdf">This article is available from https://www.excli.de/vol18/Campos_Rangel_05112019_proof.pdf</self-uri><abstract><p><italic>Marcetia taxifolia</italic> is a neotropical plant present in South America and it has been evaluated in several biological models due to the presence of active metabolites. Nevertheless, there is a limited quantity of studies related to the antiviral activity of the compounds present in this <italic>genus</italic>. In our work, the antiviral effect of the compounds isolated from the aerial parts of <italic>Marcetia taxifolia </italic>was evaluated against Hepatitis B virus (HBV), Herpes Simplex Virus type 1 (HSV-1), and Poliovirus type 1 (PV-1). The cytopathic effect and viral quantification by qPCR were determined as indicative of antiviral activity. Our data show that myricetin rhamnoside (MyrG), myricetin-3-&#x003b1;-O-ramnosil (1&#x02192;6)-&#x003b1;-galactoside (MyrGG), 5,3'-dihydroxy-3,6,7,8,4'-pentamethoxyflavone (PMF), 5-hydroxy-3,6,7,3',4'pentamethoxyflavone (PMF-OH) had antiviral activity without cytotoxic effects. The methoxyflavones PMF and PMF-OH were the most active compounds, showing an antiviral effect against all the evaluated viruses. Computational studies showed that these compounds could interact with the Reverse Transcriptase. Altogether, these results suggest that the flavonoids (related to myricetin and methoxyflavones) are the main antiviral compounds present in the aerial parts of <italic>Marcetia taxifolia</italic>. Furthermore, our results showed that the methoxyflavones have a broad antiviral activity, which represents an opportunity to evaluate these flavonoids as lead molecules to develop new antiviral compounds.</p></abstract><kwd-group><kwd>antiviral</kwd><kwd>flavonoids</kwd><kwd>Marcetia taxifolia</kwd><kwd>HBV</kwd><kwd>HSV</kwd><kwd>polio</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Emergence, resistance and spreading of viral strains promote research for new antiviral drugs. In fact, several biological compounds are found in plants and some of these plant extracts have shown broad antiviral properties. These inhibitory effects could be related to blocking main viral enzymes directly or in some cases, to be modulating a cellular pathway (Arena et al., 2004[<xref rid="R1" ref-type="bibr">1</xref>]; Jassim and Naji, 2003[<xref rid="R16" ref-type="bibr">16</xref>]; Sharma et al., 2009[<xref rid="R40" ref-type="bibr">40</xref>]). These molecular mechanisms are similar to the drugs used in antiviral therapy: direct-acting antiviral and drugs that block a host cellular process avoiding viral replication (Ortega et al., 2013[<xref rid="R32" ref-type="bibr">32</xref>]).</p><p><italic>Marcetia</italic> is a Neotropical <italic>genus</italic> distributed from Venezuela to Uruguay (Berry and Luckana, 2001[<xref rid="R4" ref-type="bibr">4</xref>]). Baptista et al. (2016[<xref rid="R3" ref-type="bibr">3</xref>]) described for the first time the compounds present in the aerial parts of <italic>Marcetia taxifolia</italic>. These compounds are: marcetol (1), 5-&#x003b1;-cholestan-3-&#x003b2;-ol (2), 5-&#x003b1;-cholestan-7-en3-&#x003b2;-ol (3), 24,25-dehydropollinastanol (4), lupa-12,20(29)-dien-3-ol (5), 5,3'- dihydroxy-3,6,7,8,4'-pentamethoxyflavone (6), 5-hydroxy-3,6,7,3',4'pentamethoxyflavone (7), myricetrine (8) and myricetin-3-&#x003b1;-O-ramnosil (1&#x02192;6)-&#x003b1;-galactoside (9). Previous reports have shown that these methoxyflavones and myricetrine have antiviral activity against HIV-1 (Ortega et al., 2017[<xref rid="R34" ref-type="bibr">34</xref>][<xref rid="R33" ref-type="bibr">33</xref>]). Additionally, Leite et al. have reported the antibacterial and antifungal activities of <italic>Marcetia taxifolia</italic> extract. These activities are principally associated with polymethoxylated flavonoids (Leite et al., 2012[<xref rid="R21" ref-type="bibr">21</xref>]). However, the antiviral activity of these compounds has been scarcely evaluated. Thus, in this study the compounds obtained from the aerial parts of <italic>Marcetia taxifolia </italic>were evaluated against three different viral families of public health concern: Hepatitis B virus (HBV), Herpes simplex virus (HSV) and Poliovirus (PV). HBV affects around 240 million people worldwide and is related to hepatic cirrhosis and hepatocellular carcinoma (WHO, 2019[<xref rid="R46" ref-type="bibr">46</xref>]). HSV may produce oral or genital lesion depending on the virus type (HSV-1 and HSV-2 respectively) (Whitley and Baines, 2018[<xref rid="R45" ref-type="bibr">45</xref>]) and Poliovirus is associated with paralysis in unvaccinated children (Menant and Gandevia, 2018[<xref rid="R26" ref-type="bibr">26</xref>]). These viruses exhibit many differences in the replicative cycle. Therefore, the aim of this study was to evaluate the antiviral activity of compounds isolated from <italic>Marcetia taxifolia</italic> against these different viral families.</p></sec><sec sec-type="materials|methods"><title>Material and Methods</title><sec><title>Cell culture, viruses, and compounds</title><p>HepG2.2.15 cells were kindly donated by Dr. Isabelle Chemin (Team leader Hepatocarcinogenesis and viral infections) from INSERM, France. These cells were grown in RPMI medium supplemented with 10 % fetal bovine serum (Gibco), 100 IU/mL penicillin G, 100 &#x000b5;g/mL streptomycin, 0.25 &#x000b5;g/mL amphotericin B and 200 &#x000b5;g/mL G418 and Vero cells in Eagle medium supplemented with 10 % fetal bovine serum (Gibco), 100 IU/ml penicillin G, 100 &#x000b5;g/mL streptomycin at 37 &#x000b0;C under 5 % CO<sub>2</sub> in a CO<sub>2</sub> incubator. Herpes simplex type 1 F strain (HSV-1), poliovirus type 1 Sabin strain (PV-1) of viral repository stocks from &#x0201c;C&#x000e1;tedra Virolog&#x000ed;a, Facultad de Farmacia y Bioqu&#x000ed;mica, UBA, Argentina&#x0201d;.</p><p>The <italic>Marcetia taxifolia</italic> (A.St.-Hil.) DC., plant collection, verification, and compound isolation were previously described (Baptista et al., 2016[<xref rid="R3" ref-type="bibr">3</xref>]). The <italic>Marcetia taxifolia</italic> (A.St.-Hil.) DC. (<italic>Melastomataceae</italic>) was collected in the Amazonanian state in Venezuela. The chemical constituents were separated through organic extraction, further isolation was developed by chromatographic techniques and the compounds were characterized using spectroscopic and spectrometric methods.</p></sec><sec><title>Cytotoxicity assay</title><p>The cytotoxicity assays were determined by the MTT method (Mosmann, 1983[<xref rid="R28" ref-type="bibr">28</xref>]). Also, the cells were seeded in 96-wells plate at a density of 1.5 x 10<sup>4</sup> cells/well. The next day, different concentrations of the flavonoid compounds were added to the cells and 24 h later, the cell viability was evaluated using the MTT (ThermoFisher, USA) cell proliferation assay as previously described (Ortega et al., 2017[<xref rid="R34" ref-type="bibr">34</xref>]). </p></sec><sec><title>HBV antiviral assay</title><p>HepG2.2.15 constitutively produces HBV particles and is broadly used to evaluate the antiviral activity (Sells et al., 1988[<xref rid="R39" ref-type="bibr">39</xref>]). The HBV production was quantified through a real-time PCR methodology, using as target the X gene. The sequence of specific primers was forwarded-1608-1627: ATG GAG ACC ACC GTG AAC GC and reversed-1887-1868 AGG CAC AGC TTG GTG GCT TG. The amplification product was of approximately 260 bp. Briefly, 24 h prior to the antiviral assay, the cells were seeded at a density of 1.2 x 10<sup>4</sup> cells / well for each condition. The cells were incubated with &#x0201c;Infection medium&#x0201d; (RPMI with 2 % FBS and 1 % DMSO) (Quintero et al., 2011[<xref rid="R38" ref-type="bibr">38</xref>]) with and without the compounds at the described concentrations. After 72 h, the medium and the compounds were refreshed by replacing them and incubated by 72 h. The supernatant was collected and viral DNA extracted using High Pure Viral Nucleic Acid Kit (Roche Life Science, Germany). The development of qPCR was done on Applied Biosystems 7300 by using a Sybr green commercial kit (Luna&#x000ae; Universal qPCR, Kit NEB Co. USA). The amplification conditions were the following: 3 min at 95 &#x000b0;C, 40 cycles of 15 sec. at 95 &#x000b0;C, 30 sec. at 61 &#x000b0;C and 30 sec. at 72 &#x000b0;C. The viral inhibition relative to control (%) was calculated. Statistical analyses of at least three independent experiments were performed. </p></sec><sec><title>Herpes virus and polio antiviral assay</title><p>To determine the antiviral activity against Herpes and Polio, a plaque reduction assay, on 24 well culture plates was performed. The Vero cells were infected with 100 plaque forming units (PFU) of HSV-1 or PV-1. After 60 min adsorption at 37 &#x000b0;C and 5 % CO<sub>2</sub> the virus was removed. Then, the monolayers were washed twice with PBS and overlaid with plaque medium (0.5 % Methylcellulose). Next, the compounds were added at different concentrations in each well and incubated by 24 or 48 h for PV-1 and HSV-1 respectively. Finally, cells were fixed with 10 % formalin and stained with 0.4 % crystal violet. Viral infection, cellular morphology, and cytotoxic controls in each assay were all performed. </p></sec><sec><title>3D model building and refinement</title><sec><title>Homology modeling</title><p>A homology model of the Hepatitis B virus Reverse Transcriptase (HBV-RT) was generated by using the crystallographic structure of HIV-1 Reverse Transcriptase (HIV-1-RT) (PDB 3V81) as the template (Daga et al., 2010[<xref rid="R8" ref-type="bibr">8</xref>]; Das et al., 2012[<xref rid="R9" ref-type="bibr">9</xref>]). The initial model was obtained with the SWISS-MODEL modeling server (Arnold et al., 2006[<xref rid="R2" ref-type="bibr">2</xref>]) and the tools of DeepView/Swiss-PdbViewer 4.01 software (Guex and Peitsch, 1997[<xref rid="R13" ref-type="bibr">13</xref>]). In this model, hydrogen atoms were added, and the partial charges were assigned for energy refinement. After that, the protein model was embedded in a 100 &#x000c5; water box. Then, energy minimization preserving the enzyme folding and optimizing the relative position between the water molecules and the fixed backbone atoms was performed. The obtained system underwent a one nanosecond (ns) molecular dynamic (MD) simulation with the following characteristics: (a) Periodic Boundary Conditions (PBC) were introduced to stabilize the simulation space; (b) the long-range electrostatic potential was treated by the Particle Mesh Ewald summation method (PME) (Toukmaji et al., 2000[<xref rid="R42" ref-type="bibr">42</xref>]); (c) Newton's equation using the r-RESPA method (Masella, 2006[<xref rid="R25" ref-type="bibr">25</xref>]) (every 4 femtoseconds (fs) for long-range electrostatic forces, 2 fs for short-range non-bonded forces, and 1 fs for bonded forces) was integrated; (d) the temperature was maintained 300 &#x000b1; 5 K by means of Langevin's algorithm (Izaguirre et al., 2012[<xref rid="R15" ref-type="bibr">15</xref>]); (e) Lennard-Jones (L-J) interactions were calculated with a cut-off of 14 &#x000c5;, the switching distance was 10 &#x000c5;, and the non-bonded pair list distance was 14 &#x000c5;; (f) a frame every 5 pico seconds (ps) was stored, yielding 2000 frames; (g) constraints with a force constant of 1000kcal/mol/&#x000c5;<sup>2 </sup>were applied to the backbone atoms (N, Ca, C, O) and gradually decreased during the simulation. The simulations were carried out in three phases: an initial period of heating from zero to 300 K over nine ps; an equilibration MD simulation of 0.1 ns, and monitored MD phase of simulation of one ns. The lowest energy frame of the MD simulation was further minimized and represented in the final structure. MD simulations described in the study were performed with NAMD 2.8 (Phillips et al., 2005[<xref rid="R37" ref-type="bibr">37</xref>])/Vega ZZ 3.1.0.21, using the CHARMM force field (Vanommeslaeghe et al., 2010[<xref rid="R44" ref-type="bibr">44</xref>]) and the Gasteiger charges. All reported minimizations were performed using the conjugate gradient algorithm until a root-median square (rms) gradient was smaller than 0.01 kcal/mol/&#x000c5;. The final model validation was carried out with ProSA (Wiederstein and Sippl, 2007[<xref rid="R47" ref-type="bibr">47</xref>]) and PROCHECK programs (Laskowski et al., 1993[<xref rid="R20" ref-type="bibr">20</xref>]).</p></sec></sec><sec><title>Molecular docking with HBV-RT</title><p>The 3D structure of each inhibitor was obtained from the PubChem database (Kim et al., 2016[<xref rid="R18" ref-type="bibr">18</xref>]) or generated by parent structure modification with VegaZZ 3.1.0.21 (Pedretti et al., 2004[<xref rid="R36" ref-type="bibr">36</xref>]). The molecular docking was performed with AutoDock 4/VegaZZ 3.1.0.21 and 30 runs conducted for each compound. Sampling in a cube of 10 &#x000c5; sides around the ligand was carried out. The results were prioritized according to the predicted free energy of binding. Then the final complexes, keeping the backbone atoms of the protein fixed and improving the mutual adaptability between ligand and enzyme were minimized.</p></sec></sec><sec sec-type="results"><title>Results</title><p>The antiviral activity of the compounds isolated from the aerial parts of <italic>M. taxifolia</italic> in <italic>in vitro</italic> models of HBV, HSV-1, and PV-1 was assayed. Table 1<xref ref-type="fig" rid="T1">(Tab. 1)</xref> summarizes the results for cytotoxicity and viral inhibition for the evaluated compounds. As indicated in this table, only: myricetin rhamnoside (MyrG), myricetine-3&#x003b1;-O-rhamnosyl (1&#x02192;6)-&#x003b1;-galactoside (MyrGG), 5,3'-dihydroxy-3,6,7,8,4'-pentamethoxyflavone (PMF) and 5-hydroxy-3,6,7,3',4'-pentamethoxyflavone (PMF-OH), were active against at least one of the evaluated viruses. Additionally, these compounds showed a scarce or non-cytotoxic effect.</p><sec><title>Antiviral activity on HSV-1 and PV-1 models</title><p>The antiviral activity of each compound against Polio-1 and HSV-1 was assayed. The myricetin related compounds did not show antiviral activity against these viruses. However, methoxyflavones exhibited activity with an EC<sub>50</sub> near to 1 &#x000b5;M against PV-1 (Figure 1<xref ref-type="fig" rid="F1">(Fig. 1)</xref>). An inhibitory effect of 90 % (PMF) and 60 % (PMF-OH) against HSV-1 was observed at a concentration of 10 &#x003bc;M (Figure 1<xref ref-type="fig" rid="F1">(Fig. 1)</xref>).</p></sec><sec><title>Antiviral activity on the HBV model</title><p>The selectivity index (SI) of the methoxyflavones (PMF and PMF-OH) against HBV was 10,000 and 102 respectively, with EC<sub>50</sub> values of 0.001 &#x000b5;M for PMF and 0.098 &#x000b5;M for PMF-OH. These compounds showed the highest antiviral activity against HBV (Figure 2A<xref ref-type="fig" rid="F2">(Fig. 2)</xref>). Additionally, MyrG presents an SI of 6667 and an EC<sub>50</sub>= 0.015 &#x000b5;M while MyrGG showed an SI of 8.3 and EC<sub>50</sub>= 12 &#x000b5;M (Figure 2B<xref ref-type="fig" rid="F2">(Fig. 2)</xref>).</p><p>Previous reports show that glycosylated flavonoids related to myricetin, as well as methoxyflavones, can inhibit the HIV-1-RT (Ortega et al., 2017[<xref rid="R33" ref-type="bibr">33</xref>]). Thus, the interaction of these compounds with the HBV reverse transcriptase (HBV-RT) as a potential target was evaluated <italic>in silico</italic>. To date, there is no experimental crystal structure of HBV-RT available. For this reason, a homology model of the HBV-RT was constructed by using the crystal structure of HIV-1-RT as a template.</p></sec><sec><title>Homology modeling</title><p>The alignment between HBV-RT and HIV-1-RT (UniProtKB O11885 and P03366) was performed using the structural alignment tool of Swiss-PdbViewer/DeepView (Figure 3<xref ref-type="fig" rid="F3">(Fig. 3)</xref>). The HIV-1-RT and HBV-RT share many of the residues involved in key protein-ligand interactions (Daga et al., 2010[<xref rid="R8" ref-type="bibr">8</xref>]). These include the YMDD motif and the catalytic triad of aspartic acid residues, Asp107, Asp229, Asp230. Some differences in the putative hydrophobic NNRTI-binding pocket were found. However, the insertion of 4 amino acids in the HBV enzyme was the major difference observed. Altogether, data suggest that HIV-1-RT and HBV-RT share enough structural and functional similarity to serve as a putative predictor for the interaction with RT inhibitors.</p><p>A structural model of the HBV-RT using the SWISS-MODEL package was generated (Figure 4<xref ref-type="fig" rid="F4">(Fig. 4)</xref>). Three main subdomains in the HBV-RT structure were identified: the finger, residues 1-49 and 90-172, the palm, residues 50-89 and 173-267 and the thumb, residues 268-351. Nevertheless, differences between the models were found (Figure 4<xref ref-type="fig" rid="F4">(Fig. 4)</xref>). Homology comparison between HBV-RT model and HIV-1-RT template suggested a similar structural conformation with a root mean square deviation (rmsd) of 2.1 &#x000c5; for the C&#x003b1; atoms (Table 2<xref ref-type="fig" rid="T2">(Tab. 2)</xref>). </p><p>The conformational differences related to the secondary structure between HIV-RT and HBV-RT were determined. The main HBV features were the elongations in 4 and 5 residues occurring in the protein loops (Figure 4 B<xref ref-type="fig" rid="F4">(Fig. 4)</xref>). The palm contains the polymerase active site and the non-nucleoside pocket located ~10 &#x000c5; apart. No differences were observed around the three aspartate residues of the catalytic triad: Asp107, Asp229, and Asp230, in HBV and corresponding in HIV-1 RT to Asp110, Asp185, and Asp186.</p></sec><sec><title>Docking at the NNRTI binding pocket</title><p>Some flavonoids have been characterized as HIV-1-RT inhibitors. Furthermore, previous reports showed that these compounds, particularly myricetin and myricetin 3-rhamnoside, could occupy the NNRTI pocket (Li et al., 2011[<xref rid="R22" ref-type="bibr">22</xref>]; Ortega et al., 2017[<xref rid="R34" ref-type="bibr">34</xref>]). Thus, molecular docking study of glycosylated flavonoids (MyrG and MyrGG) and methoxyflavones (PMF and PMF-OH) into the NNRTI pocket on the HBV-RT model were carried out. Figure 5<xref ref-type="fig" rid="F5">(Fig. 5)</xref> shows the docking representation of the MyrG (A) and PMF (B) on the HBV-RT model, and Table 3<xref ref-type="fig" rid="T3">(Tab. 3)</xref> summarizes the docking scores for the ligands evaluated in this study. The compounds that best interact with the NNRTI pocket were the methoxyflavones. However, the best-docked compound was PMF-OH, with a binding energy of -5.59 kcal/mol. The compound PMF shows binding energy of -5.33 kcal/mol. However, the glycosylated flavonoids showed lower binding energy than methoxyflavones. The best ranked binding energy was for MyrG with a binding energy of -4.61 Kcal/mol. All these results are summarized in Table 3<xref ref-type="fig" rid="T3">(Tab. 3)</xref>.</p><p>For more results see the Supplementary material.</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Plant-derived compounds represent a broad variety of chemical families. However, flavonoids have been the most widely studied as possible antivirals. Indeed, some of these compounds have been active against viruses such as HBV, Polio, and Herpes virus (Zhang et al., 2014[<xref rid="R49" ref-type="bibr">49</xref>]; Eggers, 1985[<xref rid="R11" ref-type="bibr">11</xref>]; Parvez et al., 2016[<xref rid="R35" ref-type="bibr">35</xref>]; Huang et al., 2017[<xref rid="R14" ref-type="bibr">14</xref>]). <italic>Marcetia genus </italic>plants are a source of flavonoids and have been barely studied. Thus, to determine the antiviral activity of the nine compounds isolated from the aerial parts of <italic>M. taxifolia</italic>, we selected three different <italic>in vitro</italic> models: HBV, HSV-1, and PV-1. </p><p>The results showed that only the glycosylated flavonoids related to myricetin and the methoxyflavones exhibited antiviral activity. Myricetin related compounds and methoxyflavones were active against HBV (Figure 2<xref ref-type="fig" rid="F2">(Fig. 2)</xref>). However, the most potent compounds were the methoxyflavones (Figure 2A<xref ref-type="fig" rid="F2">(Fig. 2)</xref>). In our best knowledge, this is the first report that indicates the antiviral activity of these compounds on HBV. Interestingly, other flavonoids related to myricetin such as quercetin have exhibited an antiviral effect against HBV (Cheng et al., 2015[<xref rid="R7" ref-type="bibr">7</xref>]). The methoxyflavones have been barely studied and there are just a few reports related to their antiviral activity. (Ortega et al., 2017[<xref rid="R34" ref-type="bibr">34</xref>]; Nagai et al., 1995[<xref rid="R29" ref-type="bibr">29</xref>]; Eggers, 1985[<xref rid="R11" ref-type="bibr">11</xref>]; De Meyer et al., 1991[<xref rid="R10" ref-type="bibr">10</xref>]). </p><p>Flavonoids and related compounds can interact with polymerases, especially with the reverse transcriptase (Kuete et al., 2010[<xref rid="R19" ref-type="bibr">19</xref>]; Ono et al., 1990[<xref rid="R31" ref-type="bibr">31</xref>]). Ortega et al. (2017[<xref rid="R34" ref-type="bibr">34</xref>][<xref rid="R33" ref-type="bibr">33</xref>]) described that myricetin and methoxyflavones may act as non-nucleoside Reverse Transcriptase inhibitors (NNRTI). Indeed, a Reverse Transcriptase is involved in the HBV replication cycle and this enzyme has a high similarity with the HIV-1-RT. The binding of MyrG and MyrGG on the reported NNRTI binding pocket was shown by molecular docking. Moreover, the binding energy was inversely proportional to glycosylation grade (Figure 5<xref ref-type="fig" rid="F5">(Fig. 5)</xref> and Table 3<xref ref-type="fig" rid="T3">(Tab. 3)</xref>). The methoxyflavones showed lower binding energies compared to the glycosylated compounds. Additionally, these compounds produce more hydrogen bonds, which suggest a more stable interaction with the HBV-RT. These docking results are in concordance with the antiviral activities obtained in the <italic>in vitro</italic> model of HBV. Residues that consistently within 5 &#x000c5; from docked ligands were Val87, Pro88, Asn89, Leu90, Ser92, Leu 93, Trp 103, Leu223, Ala224, Phe225, Val232, and Phe273. As shown, these results suggest the hydrophobic NNRTI pocket of HBV-RT as a potential target for new inhibitors. </p><p>To determine the antiviral spectrum of these flavonoids, two additionally viral species were selected as models. PV-1 (a single strain RNA virus) and HSV-1 (a DNA virus), which diverged from HBV in the replication mechanisms. Our data show that the glycosylated flavonoids did not have an inhibitory effect against Polio nor Herpes. These observations are in concordance with previous reports for these myricetin related compounds (Lin et al., 2000[<xref rid="R23" ref-type="bibr">23</xref>]; Castrillo et al., 1986[<xref rid="R6" ref-type="bibr">6</xref>]). The methoxyflavones displayed a potent effect against Polio and these results are in agreement with previous reports of similar compounds versus this virus (Van Hoof et al., 1984[<xref rid="R43" ref-type="bibr">43</xref>]; De Meyer et al., 1991[<xref rid="R10" ref-type="bibr">10</xref>]). However, the effect of the methoxyflavones against HSV-1 (Figure 1<xref ref-type="fig" rid="F1">(Fig. 1)</xref>) was modest compared to those observed against HBV (Figure 2a<xref ref-type="fig" rid="F2">(Fig. 2)</xref>). Altogether, these results showed that the methoxyflavones are active against Polio, Herpes, and Hepatitis B. Additionally, as previously mentioned the methoxyflavones can inhibit influenza virus and HIV-1. These viruses do not share any replicative step thus; the broad range of antiviral activity of methoxyflavones may suggest two possible inhibitory mechanisms: a) inhibiting viral polymerases by acting as non-selective inhibitors, or b) modulating a cellular process related to the viral replication cycle. Indeed, methoxyflavones have been described as inhibitors of several cellular processes, such as the cell cycle, apoptosis, kinases pathway, NFKb/AKT pathway and others (Wudtiwai et al., 2011[<xref rid="R48" ref-type="bibr">48</xref>]; Bhardwaj et al., 2016[<xref rid="R5" ref-type="bibr">5</xref>]; Faqueti et al., 2016[<xref rid="R12" ref-type="bibr">12</xref>]; Kim et al., 2014[<xref rid="R17" ref-type="bibr">17</xref>]; Ma et al., 2015[<xref rid="R24" ref-type="bibr">24</xref>]; Merlo et al., 2015[<xref rid="R27" ref-type="bibr">27</xref>]; Shi et al., 2013[<xref rid="R41" ref-type="bibr">41</xref>]; Nakao et al., 2011[<xref rid="R30" ref-type="bibr">30</xref>]). </p><p>In conclusion, the methoxyflavones showed antiviral activity against all the evaluated viruses, while the glycosylated flavonoids related to myricetin were active only on HBV. In the HBV model, the possible antiviral mechanism could be related to HBV-RT inhibition. On the other hand, the results obtained for PMF against HSV-1 and PV-1 suggest that these compounds could have another mechanism related to a cellular process modulation. However, additional pharmacological studies to establish the target of the methoxyflavones and further evaluations of glycosylated flavonoids as RT inhibitors are needed. Altogether, these results show the potential of flavonoids as antiviral lead compounds. </p></sec><sec><title>Notes</title><p>H&#x000e9;ctor Rodolfo Campos and H&#x000e9;ctor Rafael Rangel (Laboratorio de Virolog&#x000ed;a Molecular, Centro de Microbiolog&#x000ed;a y Biolog&#x000ed;a Celular, Instituto Venezolano de Investigaciones Cient&#x000ed;ficas, Caracas, Venezuela; Tel: 58 212 5041874, E-mail: hrangel@ivic.gob.ve, hrangel2006@gmail.com) contributed equally as corresponding authors.</p></sec><sec><title>Acknowledgements</title><p>This work was supported by the Agencia Nacional de Promoci&#x000f3;n Cient&#x000ed;fica y Tecnol&#x000f3;gica (ANPCyT; PICT2014-1672) to RC at C&#x000e1;tedra de Virolog&#x000ed;a, Facultad de Farmacia y Bioqu&#x000ed;mica, Universidad de Buenos Aires, IVIC project number 495. To HR at Laboratorio de Virolog&#x000ed;a Molecular, Caracas, Venezuela, and UNU Biotechnology Program for Latin America and the Caribbean UNU-BIOLAC to OJT, FP and RC.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><caption><title>Supplementary material</title></caption><media mimetype="application" mime-subtype="application/pdf" xlink:href="EXCLI-18-1037-s-001.pdf" xlink:type="simple" id="d35e624" position="anchor"/></supplementary-material></sec></body><back><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal">
<person-group><name><surname>Arena</surname><given-names>A</given-names></name><name><surname>Bisignano</surname><given-names>G</given-names></name><name><surname>Pavone</surname><given-names>B</given-names></name><name><surname>Tomaino</surname><given-names>A</given-names></name><name><surname>Bonina</surname><given-names>FP</given-names></name><name><surname>Saija</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Antiviral and immunomodulatory effect of a lyophilized extract of Capparisspinosa L. buds</article-title>
<source>Phytother Res</source>
<year>2008</year>
<volume>22</volume>
<fpage>313</fpage>
<lpage>317</lpage>
<pub-id pub-id-type="pmid">18058988</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal">
<person-group><name><surname>Arnold</surname><given-names>K</given-names></name><name><surname>Bordoli</surname><given-names>L</given-names></name><name><surname>Kopp</surname><given-names>J</given-names></name><name><surname>Schwede</surname><given-names>T</given-names></name></person-group>
<article-title>The SWISS-MODEL workspace: A web-based environment for protein structure homology modelling</article-title>
<source>Bioinformatics</source>
<year>2006</year>
<volume>22</volume>
<fpage>195</fpage>
<lpage>201</lpage>
<pub-id pub-id-type="pmid">16301204</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal">
<person-group><name><surname>Baptista</surname><given-names>J</given-names></name><name><surname>Chavez</surname><given-names>K</given-names></name><name><surname>Torrico</surname><given-names>F</given-names></name><name><surname>Trejo</surname><given-names>E</given-names></name><name><surname>Garca</surname><given-names>C</given-names></name><name><surname>Urbina</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Constituyentes qumicos y actividad antiinflamatoria de Marcetia taxifolia</article-title>
<source>Ciencia</source>
<year>2016</year>
<volume>24</volume>
<fpage>8294</fpage>
</element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Berry</surname><given-names>PE</given-names></name><name><surname>Luckana</surname><given-names>N</given-names></name></person-group>
<person-group person-group-type="editor"><name><surname>Berry</surname><given-names>PE</given-names></name><name><surname>Yatskievych</surname><given-names>K</given-names></name><name><surname>Holst</surname><given-names>BK</given-names></name></person-group>
<article-title>Melastomataceae</article-title>
<source>Flora of the Venezuelan Guayana. Liliaceae-Myrsinaceae</source>
<year>2001</year>
<edition>6th ed.</edition>
<publisher-loc>St. Louis, MI</publisher-loc>
<publisher-name>Missouri Botanical Garden</publisher-name>
<fpage>263</fpage>
<lpage>383</lpage>
</element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal">
<person-group><name><surname>Bhardwaj</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>NH</given-names></name><name><surname>Paul</surname><given-names>S</given-names></name><name><surname>Jakhar</surname><given-names>R</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Kang</surname><given-names>SC</given-names></name></person-group>
<article-title>5-Hydroxy-7-methoxyflavone triggers mitochondrial-associated cell death via reactive oxygen species signaling in human colon carcinoma cells</article-title>
<source>PLoS One</source>
<year>2016</year>
<volume>11</volume>
<issue>4</issue>
<fpage>e0154525</fpage>
<pub-id pub-id-type="pmid">27116119</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal">
<person-group><name><surname>Castrillo</surname><given-names>JL</given-names></name><name><surname>VandenBerghe</surname><given-names>D</given-names></name><name><surname>Carrasco</surname><given-names>L</given-names></name></person-group>
<article-title>3-Methylquercetin is a potent and selective inhibitor of poliovirus RNA synthesis</article-title>
<source>Virology</source>
<year>1986</year>
<volume>152</volume>
<fpage>219</fpage>
<lpage>227</lpage>
<pub-id pub-id-type="pmid">3012868</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal">
<person-group><name><surname>Cheng</surname><given-names>Z</given-names></name><name><surname>Sun</surname><given-names>G</given-names></name><name><surname>Guo</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>Inhibition of hepatitis B virus replication by quercetin in human hepatoma cell lines</article-title>
<source>Virol Sin</source>
<year>2015</year>
<volume>30</volume>
<fpage>261</fpage>
<lpage>268</lpage>
<pub-id pub-id-type="pmid">26268473</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal">
<person-group><name><surname>Daga</surname><given-names>PR</given-names></name><name><surname>Duan</surname><given-names>J</given-names></name><name><surname>Doerksen</surname><given-names>RJ</given-names></name></person-group>
<article-title>Computational model of hepatitis B virus DNA polymerase: Molecular dynamics and docking to understand resistant mutations</article-title>
<source>Protein Sci</source>
<year>2010</year>
<volume>19</volume>
<fpage>796</fpage>
<lpage>807</lpage>
<pub-id pub-id-type="pmid">20162615</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal">
<person-group><name><surname>Das</surname><given-names>K</given-names></name><name><surname>Martinez</surname><given-names>SE</given-names></name><name><surname>Bauman</surname><given-names>JD</given-names></name><name><surname>Arnold</surname><given-names>E</given-names></name></person-group>
<article-title>HIV-1 reverse transcriptase complex with DNA and nevirapine reveals non-nucleoside inhibition mechanism</article-title>
<source>Nat Struct Mol Biol</source>
<year>2012</year>
<volume>19</volume>
<fpage>2539</fpage>
</element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal">
<person-group><name><surname>De Meyer</surname><given-names>N</given-names></name><name><surname>Haemers</surname><given-names>A</given-names></name><name><surname>Mishra</surname><given-names>L</given-names></name><name><surname>Pandey</surname><given-names>HK</given-names></name><name><surname>Pieters</surname><given-names>LA</given-names></name><name><surname>VandenBerghe</surname><given-names>DA</given-names></name><etal/></person-group>
<article-title>4'-Hydroxy-3-methoxyflavones with potentantipicornavirus activity</article-title>
<source>J Med Chem</source>
<year>1991</year>
<volume>34</volume>
<fpage>736</fpage>
<lpage>746</lpage>
<pub-id pub-id-type="pmid">1847431</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal">
<person-group><name><surname>Eggers</surname><given-names>HJ</given-names></name></person-group>
<article-title>Antiviral agents against picornaviruses</article-title>
<source>Antiviral Res</source>
<year>1985</year>
<issue>Suppl 1</issue>
<fpage>57</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="pmid">3002267</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal">
<person-group><name><surname>Faqueti</surname><given-names>LG</given-names></name><name><surname>Brieudes</surname><given-names>V</given-names></name><name><surname>Halabalaki</surname><given-names>M</given-names></name><name><surname>Skaltsounis</surname><given-names>AL</given-names></name><name><surname>Nascimento</surname><given-names>LF</given-names></name><name><surname>Barros</surname><given-names>WM</given-names></name><etal/></person-group>
<article-title>Antinociceptive and anti-inflammatory activities of standardized extract of polymethoxyflavones from Ageratum conyzoides</article-title>
<source>J Ethnopharmacol</source>
<year>2016</year>
<volume>194</volume>
<fpage>369</fpage>
<lpage>377</lpage>
<pub-id pub-id-type="pmid">27633406</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal">
<person-group><name><surname>Guex</surname><given-names>N</given-names></name><name><surname>Peitsch</surname><given-names>MC</given-names></name></person-group>
<article-title>SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling</article-title>
<source>Electrophoresis</source>
<year>1997</year>
<volume>18</volume>
<fpage>2714</fpage>
<lpage>2723</lpage>
<pub-id pub-id-type="pmid">9504803</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal">
<person-group><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>P</given-names></name><name><surname>Shi</surname><given-names>X</given-names></name></person-group>
<article-title>Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs</article-title>
<source>Toxicol Appl Pharmacol</source>
<year>2017;15</year>
<volume>323</volume>
<fpage>36</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="pmid">28322895</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal">
<person-group><name><surname>Izaguirre</surname><given-names>JA</given-names></name><name><surname>Catarello</surname><given-names>DP</given-names></name><name><surname>Wozniak</surname><given-names>JM</given-names></name><name><surname>Skeel</surname><given-names>RD</given-names></name></person-group>
<article-title>Langevin stabilization of molecular dynamics</article-title>
<source>J Chem Phys</source>
<year>2012</year>
<volume>114</volume>
<fpage>2090</fpage>
</element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal">
<person-group><name><surname>Jassim</surname><given-names>SA</given-names></name><name><surname>Naji</surname><given-names>MA</given-names></name></person-group>
<article-title>Novel antiviral agents: a medicinal plant perspective</article-title>
<source>J Appl Microbiol</source>
<year>2003</year>
<volume>95</volume>
<fpage>412</fpage>
<lpage>427</lpage>
<pub-id pub-id-type="pmid">12911688</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal">
<person-group><name><surname>Kim</surname><given-names>HR</given-names></name><name><surname>Park</surname><given-names>CG</given-names></name><name><surname>Jung</surname><given-names>JY</given-names></name></person-group>
<article-title>Acacetin (5,7-dihydroxy-4'-methoxyflavone) exhibits in vitro and in vivo anticancer activity through the suppression of NF-?B/Akt signaling in prostate cancer cells</article-title>
<source>Int J Mol Med</source>
<year>2014</year>
<volume>33</volume>
<fpage>317</fpage>
<lpage>324</lpage>
<pub-id pub-id-type="pmid">24285354</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal">
<person-group><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Thiessen</surname><given-names>PA</given-names></name><name><surname>Bolton</surname><given-names>EE</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Fu</surname><given-names>G</given-names></name><name><surname>Gindulyte</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>PubChem Substance and Compound databases</article-title>
<source>Nucleic Acids Res</source>
<year>2016</year>
<volume>44</volume>
<fpage>1202</fpage>
<lpage>1213</lpage>
</element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal">
<person-group><name><surname>Kuete</surname><given-names>V</given-names></name><name><surname>Ngameni</surname><given-names>B</given-names></name><name><surname>Mbaveng</surname><given-names>AT</given-names></name><name><surname>Ngadjui</surname><given-names>B</given-names></name><name><surname>Meyer</surname><given-names>JJ</given-names></name><name><surname>Lall</surname><given-names>N</given-names></name></person-group>
<article-title>Evaluation of flavonoids from Dorstenia barteri for their antimycobacterial, antigonorrheal and anti-reverse transcriptase activities</article-title>
<source>Acta Trop</source>
<year>2010</year>
<volume>116</volume>
<fpage>100</fpage>
<lpage>104</lpage>
<pub-id pub-id-type="pmid">20599632</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal">
<person-group><name><surname>Laskowski</surname><given-names>RA</given-names></name><name><surname>MacArthur</surname><given-names>MW</given-names></name><name><surname>Moss</surname><given-names>DS</given-names></name><name><surname>Thornton</surname><given-names>JM</given-names></name></person-group>
<article-title>PROCHECK - a program to check the stereochemical quality of protein structures</article-title>
<source>J Appl Crystallogr</source>
<year>1993</year>
<volume>26</volume>
<fpage>28391</fpage>
</element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal">
<person-group><name><surname>Leite</surname><given-names>TC</given-names></name><name><surname>de Sena</surname><given-names>AR</given-names></name><name><surname>Dos Santos Silva</surname><given-names>TR</given-names></name><name><surname>Dos Santos</surname><given-names>AK</given-names></name><name><surname>Uetanabaro</surname><given-names>AP</given-names></name><name><surname>Branco</surname><given-names>A</given-names></name></person-group>
<article-title>Antimicrobial activity of Marcetia DC species (Melastomataceae) and analysis of its flavonoids by reverse phase-high performance liquid chromatography coupled-diode array detector</article-title>
<source>Pharmacogn Mag</source>
<year>2012</year>
<volume>8</volume>
<issue>31</issue>
<fpage>209</fpage>
<lpage>214</lpage>
<pub-id pub-id-type="pmid">23060695</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal">
<person-group><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Hattori</surname><given-names>T</given-names></name><name><surname>Kodama</surname><given-names>EN</given-names></name></person-group>
<article-title>Epigallocatechin gallate inhibits the HIV reverse transcription step</article-title>
<source>Antivir Chem Chemother</source>
<year>2011</year>
<volume>21</volume>
<fpage>239</fpage>
<lpage>243</lpage>
<pub-id pub-id-type="pmid">21730371</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal">
<person-group><name><surname>Lin</surname><given-names>LC</given-names></name><name><surname>Kuo</surname><given-names>YC</given-names></name><name><surname>Chou</surname><given-names>CJ</given-names></name></person-group>
<article-title>Anti-herpes simplex virus type-1 flavonoids and a new flavanone from the root of Limonium sinense</article-title>
<source>Planta Med</source>
<year>2000</year>
<volume>66</volume>
<fpage>333</fpage>
<lpage>336</lpage>
<pub-id pub-id-type="pmid">10865449</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal">
<person-group><name><surname>Ma</surname><given-names>W</given-names></name><name><surname>Feng</surname><given-names>S</given-names></name><name><surname>Yao</surname><given-names>X</given-names></name><name><surname>Yuan</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name></person-group>
<article-title>Nobiletin enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cancer cells</article-title>
<source>Sci Rep</source>
<year>2015</year>
<volume>5</volume>
<fpage>18789</fpage>
<pub-id pub-id-type="pmid">26689156</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal">
<person-group><name><surname>Masella</surname><given-names>M</given-names></name></person-group>
<article-title>The multiple time step r-RESPA procedure and polarizable potentials based on induced dipole moments</article-title>
<source>Mol Phys</source>
<year>2006</year>
<volume>104</volume>
<fpage>41528</fpage>
</element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal">
<person-group><name><surname>Menant</surname><given-names>JC</given-names></name><name><surname>Gandevia</surname><given-names>SC</given-names></name></person-group>
<article-title>Poliomyelitis</article-title>
<source>Handb Clin Neurol</source>
<year>2018</year>
<volume>159</volume>
<fpage>337</fpage>
<lpage>344</lpage>
<pub-id pub-id-type="pmid">30482325</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal">
<person-group><name><surname>Merlo</surname><given-names>S</given-names></name><name><surname>Basile</surname><given-names>L</given-names></name><name><surname>Giuffrida</surname><given-names>ML</given-names></name><name><surname>Sortino</surname><given-names>MA</given-names></name><name><surname>Guccione</surname><given-names>S</given-names></name><name><surname>Copani</surname><given-names>A</given-names></name></person-group>
<article-title>Identification of 5-methoxyflavone as a novel DNA polymerase-beta inhibitor and neuroprotective agent against beta-amyloid toxicity</article-title>
<source>J Nat Prod</source>
<year>2015</year>
<volume>78</volume>
<fpage>2704</fpage>
<lpage>2711</lpage>
<pub-id pub-id-type="pmid">26517378</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal">
<person-group><name><surname>Mosmann</surname><given-names>T</given-names></name></person-group>
<article-title>MTT rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays</article-title>
<source>J Immunol Methods</source>
<year>1983</year>
<volume>65</volume>
<fpage>55</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="pmid">6606682</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal">
<person-group><name><surname>Nagai</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Tomimori</surname><given-names>T</given-names></name><name><surname>Yamada</surname><given-names>H</given-names></name></person-group>
<article-title>Antiviral activity of plant flavonoid, 5,7,4'-trihydroxy-8-methoxyflavone, from the roots of Scutellaria baicalensis against influenza A (H3N2) and B viruses</article-title>
<source>Biol Pharm Bull</source>
<year>1995</year>
<volume>18</volume>
<fpage>295</fpage>
<lpage>299</lpage>
<pub-id pub-id-type="pmid">7742801</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal">
<person-group><name><surname>Nakao</surname><given-names>K</given-names></name><name><surname>Murata</surname><given-names>K</given-names></name><name><surname>Deguchi</surname><given-names>T</given-names></name><name><surname>Itoh</surname><given-names>K</given-names></name><name><surname>Fujita</surname><given-names>T</given-names></name><name><surname>Higashino</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Xanthine oxidase inhibitory activities and crystal structures of methoxyflavones from Kaempferia parviflora rhizome</article-title>
<source>Biol Pharm Bull</source>
<year>2011</year>
<volume>34</volume>
<fpage>1143</fpage>
<lpage>1146</lpage>
<pub-id pub-id-type="pmid">21720029</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal">
<person-group><name><surname>Ono</surname><given-names>K</given-names></name><name><surname>Nakane</surname><given-names>H</given-names></name><name><surname>Fukushima</surname><given-names>M</given-names></name><name><surname>Chermann</surname><given-names>JC</given-names></name><name><surname>Barr-Sinoussi</surname><given-names>F</given-names></name></person-group>
<article-title>Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases</article-title>
<source>Eur J Biochem</source>
<year>1990</year>
<volume>190</volume>
<fpage>469</fpage>
<lpage>476</lpage>
<pub-id pub-id-type="pmid">1695572</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal">
<person-group><name><surname>Ortega</surname><given-names>JT</given-names></name><name><surname>Rangel</surname><given-names>HR</given-names></name><name><surname>Pujol</surname><given-names>FH</given-names></name></person-group>
<article-title>Cellular targets as an alternative mechanism in antiviral therapy</article-title>
<source>Interciencia</source>
<year>2013</year>
<volume>38</volume>
<fpage>836</fpage>
<lpage>842</lpage>
</element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal">
<person-group><name><surname>Ortega</surname><given-names>JT</given-names></name><name><surname>Serrano</surname><given-names>ML</given-names></name><name><surname>Surez</surname><given-names>AI</given-names></name><name><surname>Baptista</surname><given-names>J</given-names></name><name><surname>Pujol</surname><given-names>FH</given-names></name><name><surname>Rangel</surname><given-names>HR</given-names></name></person-group>
<article-title>Methoxyflavones from Marcetia taxifolia as HIV-1 reverse transcriptase inhibitors</article-title>
<source>Natural Product Commun</source>
<year>2017</year>
<volume>12</volume>
<fpage>1677</fpage>
<lpage>1680</lpage>
</element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal">
<person-group><name><surname>Ortega</surname><given-names>JT</given-names></name><name><surname>Surez</surname><given-names>AI</given-names></name><name><surname>Serrano</surname><given-names>ML</given-names></name><name><surname>Baptista</surname><given-names>J</given-names></name><name><surname>Pujol</surname><given-names>FH</given-names></name><name><surname>Rangel</surname><given-names>HR</given-names></name></person-group>
<article-title>The role of the glycosyl moiety of myricetin derivatives in anti-HIV-1 activity in vitro</article-title>
<source>AIDS Res Ther</source>
<year>2017</year>
<volume>14</volume>
<issue>1</issue>
<fpage>57</fpage>
<pub-id pub-id-type="pmid">29025433</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal">
<person-group><name><surname>Parvez</surname><given-names>MK</given-names></name><name><surname>Arbab</surname><given-names>AH</given-names></name><name><surname>Al-Dosari</surname><given-names>MS</given-names></name><name><surname>Al-Rehaily</surname><given-names>AJ</given-names></name></person-group>
<article-title>Antiviral natural products against chronic hepatitis B: Recent developments</article-title>
<source>Curr Pharm Des</source>
<year>2016</year>
<volume>22</volume>
<fpage>286</fpage>
<lpage>293</lpage>
<pub-id pub-id-type="pmid">26561057</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal">
<person-group><name><surname>Pedretti</surname><given-names>A</given-names></name><name><surname>Villa</surname><given-names>L</given-names></name><name><surname>Vistoli</surname><given-names>G</given-names></name></person-group>
<article-title>VEGA - An open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming</article-title>
<source>J Comput Aided Mol Des</source>
<year>2004</year>
<volume>18</volume>
<fpage>16773</fpage>
</element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal">
<person-group><name><surname>Phillips</surname><given-names>JC</given-names></name><name><surname>Braun</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Gumbart</surname><given-names>J</given-names></name><name><surname>Tajkhorshid</surname><given-names>E</given-names></name><name><surname>Villa</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Scalable molecular dynamics with NAMD</article-title>
<source>J Comput Chem</source>
<year>2005</year>
<volume>26</volume>
<fpage>1781802</fpage>
</element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal">
<person-group><name><surname>Quintero</surname><given-names>A</given-names></name><name><surname>Fabbro</surname><given-names>R</given-names></name><name><surname>Maillo</surname><given-names>M</given-names></name><name><surname>Barrios</surname><given-names>M</given-names></name><name><surname>Milano</surname><given-names>MB</given-names></name><name><surname>Fernndez</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Inhibition of hepatitis B virus and human immunodeficiency virus (HIV-1) replication by Warscewiczia coccinea (Vahl) Kl. (Rubiaceae) ethanol extract</article-title>
<source>Nat Prod Res</source>
<year>2011</year>
<volume>25</volume>
<fpage>1565</fpage>
<lpage>1569</lpage>
<pub-id pub-id-type="pmid">21827337</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal">
<person-group><name><surname>Sells</surname><given-names>MA</given-names></name><name><surname>Zelent</surname><given-names>AZ</given-names></name><name><surname>Shvartsman</surname><given-names>M</given-names></name><name><surname>Acs</surname><given-names>G</given-names></name></person-group>
<article-title>Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions</article-title>
<source>J Virol</source>
<year>1988</year>
<volume>62</volume>
<fpage>2836</fpage>
<lpage>2844</lpage>
<pub-id pub-id-type="pmid">2839705</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal">
<person-group><name><surname>Sharma</surname><given-names>M</given-names></name><name><surname>Anderson</surname><given-names>SA</given-names></name><name><surname>Schoop</surname><given-names>R</given-names></name><name><surname>Hudson</surname><given-names>JB</given-names></name></person-group>
<article-title>Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract</article-title>
<source>Antiviral Res</source>
<year>2009</year>
<volume>83</volume>
<fpage>165</fpage>
<lpage>170</lpage>
<pub-id pub-id-type="pmid">19409931</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal">
<person-group><name><surname>Shi</surname><given-names>MD</given-names></name><name><surname>Liao</surname><given-names>YC</given-names></name><name><surname>Shih</surname><given-names>YW</given-names></name><name><surname>Tsai</surname><given-names>LY</given-names></name></person-group>
<article-title>Nobiletin attenuates metastasis via both ERK and PI3K/Akt pathways in HGF-treated liver cancer HepG2 cells</article-title>
<source>Phytomedicine</source>
<year>2013</year>
<volume>20</volume>
<fpage>743</fpage>
<lpage>752</lpage>
<pub-id pub-id-type="pmid">23537747</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal">
<person-group><name><surname>Toukmaji</surname><given-names>A</given-names></name><name><surname>Sagui</surname><given-names>C</given-names></name><name><surname>Board</surname><given-names>J</given-names></name><name><surname>Darden</surname><given-names>T</given-names></name></person-group>
<article-title>Efficient particle-mesh Ewald based approach to fixed and induced dipolar interactions</article-title>
<source>J Chem Phys</source>
<year>2000</year>
<volume>113</volume>
<fpage>1091327</fpage>
</element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal">
<person-group><name><surname>Van Hoof</surname><given-names>L</given-names></name><name><surname>Berghe</surname><given-names>DA</given-names></name><name><surname>Hatfield</surname><given-names>GM</given-names></name><name><surname>Vlietinck</surname><given-names>AJ</given-names></name></person-group>
<article-title>3-Methoxyflavones as potent inhibitors of viral-induced block of cell synthesis</article-title>
<source>Planta Med</source>
<year>1984</year>
<volume>50</volume>
<fpage>513</fpage>
<lpage>517</lpage>
</element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal">
<person-group><name><surname>Vanommeslaeghe</surname><given-names>K</given-names></name><name><surname>Hatcher</surname><given-names>E</given-names></name><name><surname>Acharya</surname><given-names>C</given-names></name><name><surname>Kundu</surname><given-names>S</given-names></name><name><surname>Zhong</surname><given-names>S</given-names></name><name><surname>Shim</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields</article-title>
<source>J Comput Chem</source>
<year>2010</year>
<volume>31</volume>
<fpage>67190</fpage>
</element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal">
<person-group><name><surname>Whitley</surname><given-names>R</given-names></name><name><surname>Baines</surname><given-names>J</given-names></name></person-group>
<article-title>Clinical management of herpes simplex virus infections: past, present, and future</article-title>
<source>F1000Res</source>
<year>2018</year>
<volume>7</volume>
<fpage>F1000 Faculty Rev</fpage>
<lpage>F1000 Faculty1726</lpage>
</element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="book">
<collab>WHO</collab>
<article-title>Hepatitis B</article-title>
<year>2019</year>
<publisher-loc>Geneva</publisher-loc>
<publisher-name>WHO</publisher-name>
<comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/news-room/fact-sheets/detail/hepatitis-b">https://www.who.int/news-room/fact-sheets/detail/hepatitis-b</ext-link></comment>
</element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal">
<person-group><name><surname>Wiederstein</surname><given-names>M</given-names></name><name><surname>Sippl</surname><given-names>MJ</given-names></name></person-group>
<article-title>ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins</article-title>
<source>Nucleic Acids Res</source>
<year>2007</year>
<volume>35</volume>
<fpage>W40710</fpage>
</element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal">
<person-group><name><surname>Wudtiwai</surname><given-names>B</given-names></name><name><surname>Sripanidkulchai</surname><given-names>B</given-names></name><name><surname>Kongtawelert</surname><given-names>P</given-names></name><name><surname>Banjerdpongchai</surname><given-names>R</given-names></name></person-group>
<article-title>Methoxyflavone derivatives modulate the effect of TRAIL-induced apoptosis in human leukemic cell lines</article-title>
<source>J Hematol Oncol</source>
<year>2011</year>
<volume>4</volume>
<fpage>52</fpage>
<pub-id pub-id-type="pmid">22185222</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal">
<person-group><name><surname>Zhang</surname><given-names>QG</given-names></name><name><surname>Wei</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>LJ</given-names></name><name><surname>Liu</surname><given-names>YY</given-names></name><name><surname>Luo</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>The flavonoid from Polygonum perfoliatum L. inhibits herpes simplex virus 1 infection</article-title>
<source>ActaVirol</source>
<year>2014</year>
<volume>58</volume>
<fpage>368</fpage>
<lpage>373</lpage>
</element-citation></ref></ref-list></back><floats-group><fig id="T1" position="float"><label>Table 1</label><caption><title>Cytotoxic concentration and Inhibitory concentration of the tested compounds</title></caption><graphic xlink:href="EXCLI-18-1037-t-001"/></fig><fig id="T2" position="float"><label>Table 2</label><caption><title>Structural comparison between the HBV-RT model and HIV-1-RT</title></caption><graphic xlink:href="EXCLI-18-1037-t-002"/></fig><fig id="T3" position="float"><label>Table 3</label><caption><title>Docking results of the evaluated compounds using the HBV-RT model</title></caption><graphic xlink:href="EXCLI-18-1037-t-003"/></fig><fig id="F1" position="float"><label>Figure 1</label><caption><title>Antiviral activity of methoxyflavones against PV-1 and HSV-1</title></caption><graphic xlink:href="EXCLI-18-1037-g-001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>Antiviral activity of <italic>Marcetia taxifolia</italic> flavonoids against HBV. (A) methoxyflavones: PMF and PMF-OH, (B) Myricetin glycosides: MyrG and MyrGG</title></caption><graphic xlink:href="EXCLI-18-1037-g-002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>Sequence alignment of HBV-RT and HIV-1-RT polymerases. Secondary structure prediction of HBV-RT. Predicted amino acid sequences of HBV-RT (O11885) and HIV-1-RT PDB code 3v81 (P03366) were accordingly to Daga et al. (2010) conserved residues, which are highlighted with a red background.</title></caption><graphic xlink:href="EXCLI-18-1037-g-003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>Comparison between the homology model of HBV-RT and the crystal structure of HIV-1-RT. (A) Ribbon diagram of HBV-RT. Three subdomains are described: Fingers (residues 1-49 and 90-172, purple), palm (residues 50-89 and 173-267, blue), and thumb (residues 268-351, green). (B) HBV-RT (blue) and HIV-1-RT (yellow) are superimposed; regions showing significant differences are marked (*). Amino acids of the catalytic triad and Nevirapine are displayed in sticks.</title></caption><graphic xlink:href="EXCLI-18-1037-g-004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><title>Docking results of MyrG (A) and PMF (B) over the HBV-RT model. 3D representations of the complex interactions categorized by hydrogen bonds (green dashed lines), &#x003c0;-stacks (pink-dashed lines).</title></caption><graphic xlink:href="EXCLI-18-1037-g-005"/></fig></floats-group></article>